Key Takeaways New research shows CGRP-targeted therapies can help migraine sufferers These medications block a protein that ...
Atogepant led to improvements and showed no new safety signals in patients with chronic and episodic migraine after 3 years ...
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Chronic migraine is a debilitating condition that’s both painful and frustrating. It’s defined as 15 or ...
Digital migraine platform shows improved patient outcomes and supports continuous care models for clinics These results ...
Eptinezumab plus education reduces monthly migraine days in adults with chronic migraine and medication-overuse headache.
Woman's World on MSN
Could a GLP-1 drug cut your migraine days in half? Research says yes
If you've ever had to draw the curtains, silence your phone and crawl into bed because a migraine has taken over your day, ...
COLORADO SPRINGS, Colo. -- Every 12 weeks, Shannon Stone goes to her neurologist to get Botox injected in and around her head. Not for cosmetic reasons, but for chronic migraines. “I’ve been working ...
Eptinezumab is associated with modest reductions in headache frequency for patients with chronic migraine with inadequate ...
Jennifer Whetstone first felt the pain, like a sledgehammer coming down on the top of her head, when she was 16 years old. It was her first migraine attack, but it wouldn’t be the last—soon that ...
New data show early and sustained weight loss with atogepant, raising the possibility of metabolic benefits beyond migraine prevention.
Chronic migraine can be a debilitating medical condition. Healthline spoke with four people managing migraine and raising awareness to help others. Migraine is a complex neurological condition. While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results